TCL Archive Groups Point to NCI Restrictions As Source Of Problems, Discuss Prioritizing Trials July 11, 2003
TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive DCCP Board Gives Concept Approval To RFA For Biochemical Epidemiolgy, New And Recompeting Contract Program September 23, 1983
TCL Archive Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected October 1, 1976
TCL Archive Cancer Center Directors Say Collaboration, Funding, and Application of Best Practices Will Reduce the Burden of Cancer. September 15, 2006
